Emtricitabine and Raltegravir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Emtricitabine and Raltegravir. Common interactions include asterixis among females and drug resistance among males.
The phase IV clinical study analyzes what interactions people who take Emtricitabine and Raltegravir have. It is created by eHealthMe based on reports of 685 people who take Emtricitabine and Raltegravir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
685 people who take Emtricitabine and Raltegravir together, and have interactions are studied.
What is Emtricitabine?
Emtricitabine has active ingredients of emtricitabine. eHealthMe is studying from 5,611 Emtricitabine users for its effectiveness, alternative drugs and more.
What is Raltegravir?
Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 4,258 Raltegravir users for its effectiveness, alternative drugs and more.
Number of Emtricitabine and Raltegravir reports submitted per year:
Emtricitabine and Raltegravir drug interactions by gender *:
Emtricitabine and Raltegravir drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Emtricitabine and Raltegravir?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Emtricitabine (5,611 reports)
- Raltegravir (4,258 reports)
Common Emtricitabine and Raltegravir interactions:
- Death: 29 reports
Browse all drug interactions of Emtricitabine and Raltegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Emtricitabine side effects:
- Nausea and vomiting: 155 reports
- Drug ineffective: 150 reports
- Death: 149 reports
- Fatigue (feeling of tiredness): 135 reports
Browse all side effects of Emtricitabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Raltegravir side effects:
- Depression: 331 reports
- Drug ineffective: 161 reports
- Fever: 135 reports
- Fatigue (feeling of tiredness): 134 reports
- Death: 133 reports
Browse all side effects of Raltegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Emtricitabine interactions:
- Emtricitabine and Tenofovir disoproxil fumarate: 1,576 reports
- Emtricitabine and Efavirenz: 1,425 reports
- Emtricitabine and Ritonavir: 1,240 reports
- Emtricitabine and Darunavir: 722 reports
- Emtricitabine and Nevirapine: 663 reports
- Emtricitabine and Abacavir: 598 reports
- Emtricitabine and Dolutegravir: 487 reports
- Emtricitabine and Didanosine: 425 reports
- Emtricitabine and Stavudine: 305 reports
Browse all interactions between Emtricitabine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Raltegravir interactions:
- Raltegravir and Ritonavir: 1,156 reports
- Raltegravir and Darunavir: 1,146 reports
- Raltegravir and Efavirenz: 659 reports
- Raltegravir and Abacavir: 585 reports
- Raltegravir and Etravirine: 564 reports
- Raltegravir and Truvada: 544 reports
- Raltegravir and Tenofovir disoproxil fumarate: 504 reports
- Raltegravir and Kaletra: 496 reports
- Raltegravir and Atazanavir sulfate: 363 reports
Browse all interactions between Raltegravir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on emtricitabine and raltegravir (the active ingredients of Emtricitabine and Raltegravir, respectively), and Emtricitabine and Raltegravir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Emtricitabine and Raltegravir.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Brimonidine Tartrate and Dizziness - 14 seconds ago
- Benztropine Mesylate and Haldol drug interaction - 17 seconds ago
- Epipen and Entecavir drug interaction - 27 seconds ago
- Raltegravir and Drug Ineffective - 47 seconds ago
- Mysoline and Optic Neuropathy - 53 seconds ago
- Metoprolol Tartrate and Red Blood Cell Count Increased - 59 seconds ago
- Nebivolol Hydrochloride and Coronary Artery Occlusion - a minute ago
- Nebivolol Hydrochloride and Confusional State - a minute ago
- Nebivolol Hydrochloride and Hyponatremia - a minute ago
- Nebivolol Hydrochloride and Abdominal Pain Upper - a minute ago